The latest news from oncology events around the world
In this, large, phase 3 trial, ripretinib was not found to be better than sunitinib…
“The current standard of care for inoperable biliary tract cancer is combined chemotherapy. That standard…
“To date, the HIMALAYA study is one of the largest phase III studies conducted with…
New results for higher dose level cohorts of the investigational study REGN5458 (BCMAxCD3) bispecific antibody,…
Young patients with chronic lymphocytic leukaemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to…
A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient’s (host)…
Mount Sinai physician-scientists in the USA have found that a novel therapy for the bone…
In a phase III trial, a combination of ivosidenib and azacitidine was found superior in…
A study of nearly 25,000 young people with ALL reveals significant gaps in survival rates…
Patients receiving the anti-CD38 monoclonal antibody isatuximab in addition to the standard three- component induction…